Qkine Limited and Akron Bio Announce Strategic Partnership
Collaboration to Deliver High-Quality Cytokines and Growth Factors to Enable the Advancement of Stem Cell-Based Therapeutics.
Psyomics launches beseen for neurodiversity in collaboration with Mids Partnership University NHS
Psyomics has launched beseen for neurodiversity, a new digital tool that supports NHS services struggling to meet the demand of neurodevelopmental referrals and backlogs.
mOm Incubators Receives FDA Clearance for First-of-its-Kind Portable Incubator for Premature Babies
Unique, easy-to-use lightweight incubator enables care anywhere and everywhere while avoiding separation of mother and baby
Potential for novel incubator to address key aspects of preterm neonatal care and reduce dependence on NICU
Axol Bioscience secures $2.8m funding
Axol Bioscience, which has facilities in Cambridge and Edinburgh, has raised $2.8 million (£2.1m) funding to accelerate product development, scale up cell manufacturing and progress US expansion plans.
OXFORD SPACE SYSTEMS AND SSTL ANNOUNCE SUCCESSFUL LAUNCH OF CARBSAR IOD SATELLITE
Oxford Space Systems and Surrey Satellite Technology Ltd (SSTL) have announced the successful launch of CarbSAR IOD, SSTL’s latest Synthetic Aperture Radar (SAR) technology demonstration satellite incorporating Oxford Space Systems’ innovative Wrapped Rib Antenna. The spacecraft was launched aboard a Falcon 9 rocket operated by SpaceX from Vandenberg Space Force Base, California.
Nova Pangaea Technologies Appoints New CEO to Lead Global Growth
Nova Pangaea Technologies, the sustainable aviation fuel specialist backed by International Airlines Group, has appointed veteran cleantech leader Stewart Stewart as CEO.
CyberSmart joins NCRCG to support SMEs and MSPs
The National Cyber Resilience Centre Group (NCRCG) has welcomed CyberSmart as a National Ambassador to support UK SMEs and MSPs in strengthening cyber-resilience.
Oxford Drug Design reports major in vivo milestone for novel cancer therapy
Oxford Drug Design has announced new in vivo results that further validate its emerging first‑in‑class oncology programme, marking a significant step forward for the Oxford-based AI drug discovery company.
Qureight appoints Rebecca Simmons as Chief Operating Officer
Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered CT imaging biomarkers and clinical data management platform in clinical trials, today announced the appointment of Rebecca Simmons as Chief Operating Officer.
Qureight appoints Dr Steven Bishop as Chief Medical Officer
Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered CT imaging biomarkers and clinical data management platform in clinical trials, today announced the appointment of Dr Steven Bishop as Chief Medical Officer (CMO). Previously Chief Data Officer, Steven’s new role reflects changes in company structure, in response to continued growth and commercial success.
Ones to Watch - North East companies tipped for greatness in 2026
In the last of our end-of-year pieces, business writers Coreena Ford and Tom Keighley pick their five companies to watch in 2026
New trial for Walsall heart failure patients
Heart failure patients are being sought by Walsall researchers to take part in a trial to test a new device aimed at preventing deterioration and helping them avoid hospital admission.
Paragraf pioneers world-leading 6-inch wafer at its Cambridgeshire factory
Cambridge Cluster company Paragraf, which is pioneering the commercialisation of graphene-based electronics using standard semiconductor processes, has produced the first 6-inch wafer at its new manufacturing facility in Huntingdon – marking a significant expansion in the company’s production capability and technology platform.
Atelerix and Labskin partner to enable long-distance transport of advanced in vitro skin models
Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced an agreement with Labskin, a global leader in laboratory-grown human skin models used for research, testing and product development.
Asendia and HubBox announce partnership to deliver global out-of-home delivery solutions
Asendia, a leading global provider of international e-commerce and parcel delivery solutions, announces a partnership with HubBox, a pioneer in out-of-home (OOH) delivery software. Together, the companies will empower retailers to offer secure, convenient, and flexible cross-border delivery solutions to shoppers worldwide
Out-of-home delivery software group HubBox raises £6m
The investment was led by Puma Growth Partners.
Digital platform to tackle ADHD waiting list timebomb
Amid experts warning that ADHD patients are being left suicidal because of lack of medical support, a ground-breaking platform by Psyomics that can speed up access to services for diagnosis and treatment is being launched in the NHS.
VividQ: Interview With Co-Founder & CEO Darran Milne About The Holographic Display Company
VividQ develops holographic display technology for next-generation AR/VR devices. Pulse 2.0 interviewed VividQ co-founder and CEO Darran Milne to gain a deeper understanding of the company.
DIGITAL HEALTH BREAKTHROUGH AS PSYOMICS JOINS FORCES WITH NORTH LONDON NHS FOUNDATION TRUST
In a major step towards modernising mental health care, the North London NHS Foundation Trust (NLFT) has entered into a strategic partnership with digital health innovator Psyomics to transform how more than 1.6 million residents across Barnet, Camden, Enfield, Haringey and Islington access support.
Innovative climate tech ventures join EarthScale’s inaugural cohort
EarthScale, a pioneering UK-wide programme, led by Imperial College London, has officially launched with its first cohort.